Finance

Beta
Lists
26CA:FRA
Immunitybio Inc
€5.97
-5.69%
(-0.36) 1D
Jun 5, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 26CA...
Open
€6.20
High
€6.21
Low
€5.97
Mkt. cap
7.25B
Avg. vol.
496.00
Volume
0.00
52-wk high
€10.40
52-wk low
€1.68
No. of employees
688
Open
€6.20
High
€6.21
Low
€5.97
Mkt. cap
7.25B
Avg. vol.
496.00
Volume
0.00
52-wk high
€10.40
52-wk low
€1.68
No. of employees
688
News stories
From sources across the web
About Immunitybio Inc
CEORich Adcock
Employees688
Founded2014
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
26.42M
32.06M
38.28M
44.21M
Cost of goods sold
136.00K
177.00K
382.00K
238.00K
Cost of revenue
136.00K
177.00K
382.00K
238.00K
Research and development expenses
54.14M
50.13M
67.26M
67.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.44M
37.38M
35.33M
45.77M
Operating expense
97.57M
87.51M
102.59M
113.76M
Total operating expenses
97.71M
87.69M
102.97M
114.00M
Operating income
-71.28M
-55.63M
-64.68M
-69.79M
Other non operating income
6.71M
13.84M
27.48M
-529.45M
EBT including unusual items
-92.30M
-67.31M
-62.09M
-632.79M
EBT excluding unusual items
-92.30M
-67.31M
-62.09M
-625.39M
Income tax expense
269.00K
-35.00K
-135.00K
9.00K
Effective tax rate
-0.29%
0.05%
0.22%
-
Other operating expenses
-
-
-
-
Net income
-92.56M
-67.25M
-61.94M
-632.78M
Net profit margin
-350.26%
-209.77%
-161.80%
-1,431.44%
Earnings per share
-0.10
-0.07
-0.06
-0.08
Interest and investment income
1.15M
2.07M
2.30M
2.31M
Interest expense
-28.88M
-27.58M
-27.19M
-28.46M
Net interest expenses
-27.73M
-25.52M
-24.89M
-26.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
-67.40M
-51.68M
-60.92M
-65.41M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more